Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Staghorn69on Feb 22, 2018 10:53pm
144 Views
Post# 27606954

RE:RE:its important to note that

RE:RE:its important to note that
DryBones wrote: Those are the facts Gobbs,  However, the FDA is government agency and delays happen there regardless.  I for one will be delighted when they give approval and estatic is they give approval before PLI steps in more manure.  It is the future of the shareholder that is at stake here.  Not the company's, they will muddle along whatever happens.



I have little doubt that 90+% of the posters here are eaither paid pumpers or paid bashers.  The stock is clearly headed back down now where PLI management will pull off some sucker deal that benefits them with their millions of options and RSUs while
the old shareholder that carried them wither and die.  Tell me I’m wrong Fred.  The TA looks bad now and we’ll drift back down where a weak deal is done just in time for some lame US bank to
line their pockets BEFORE any FDA news is in....  all to benefit them in the long run...  with all
the long time pumpers telling us what a great deal it really is all the way to a 5-1 reverse split then dilution.  
Bullboard Posts